Cell viability assays showed that HectH9 knockdown markedly impaired cell survival in prostate, breast and cervical cancer cells regardless of p53 status (Fig. 4f–h and Supplementary Fig. 3d-f). Here, HUWE1 is linked to cervical carcinoma.